Pericardial effusions on anti-TNF therapy for rheumatoid arthritis - A drug side effect or uncontrolled systemic disease?

Rheumatology

Volumn 48, Issue 3, 2009, Pages 316-317

  Edwards, M H ^a,b   Leak, A M ^a  

^a EAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE; TACROLIMUS; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; CASE REPORT; CELLULITIS; DISEASE CONTROL; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; DRUG TREATMENT FAILURE; DYSPNEA; ECHOCARDIOGRAPHY; HUMAN; LEG ULCER; LETTER; LIVEDO RETICULARIS; MALE; PERICARDIAL EFFUSION; PERICARDITIS; PLEURA EFFUSION; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; SENSORY NEUROPATHY; SURGICAL DRAINAGE; VASCULITIS;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MALE; MIDDLE AGED; PERICARDIAL EFFUSION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 61349127957     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken463     Document Type: Letter

References (10)

1. Boers M, Croonen AM, Dijkmans BAC et al. Renal findings in rheumatoid arthritis. Clinical aspects of 132 necroscopies. Ann Rheum Dis 1987;46:658-63.
2. Puéchal X, Miceli-Richard C, Mejjad O et al. Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis. Ann Rheum Dis 2008;67:880-4.
3. Brooklyn TN, Dunnill MGS, Shetty A et al. Infliximab for the treatment of pyoderma gangrenosum: A randomised, double blind, placebo controlled trial. Gut 2006;55:505-9.
4. Harney S, O-Shea FD, FitzGerald O. Peptostreptococcal pericarditis complicating anti-tumour necrosis factor alpha treatment in rheumatoid arthritis. Ann Rheum Dis 2002;61:653-4.
5. Sweet DD, Isac G, Morrison B, Fenwick J, Dhingra V. Purulent pericarditis in a patient with rheumatoid arthritis treated with etanercept and methotrexate. Can J Emerg Med 2007;9:40-2.
6. Benucci M, Gobbi FL, Fossi F, Manfredi M, Del Rosso A. Drug-induced lupus after treatment with infliximab in rheumatoid arthritis. J Clin Rheumatol 2005;11:47-9.
7. Cush JJ. Unusual toxicities with TNF inhibition: Heart failure and drug-induced lupus. Clin Exp Rheumatol 2004;22(Suppl. 35):S141.
8. Jarrett SJ, Cunnane G, Conaghan PG et al. Anti-tumor necrosis factor-α therapy induced vasculitis: Case series. J Rheumatol 2004;30:2287-91.
9. Mohan N, Edwards ET, Cupps TR et al. Leukocytoclastic vasculitis associated with tumor necrosis factor-α therapy. J Rheumatol 2004;31:1955-8.
10. Rozenbaum M, Boulman N, Slobodin G, Ayubkhanov E, Rosner I. Polyarthritis flare complicating rheumatoid arthritis infliximab therapy: A paradoxic adverse reaction. J Clin Rheumatol 2006;12:269-71.